Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 15 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

3 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

10 recruiting

Enrollment Performance

Analytics

N/A

4(50.0%)

Phase 4

3(37.5%)

Phase 2

1(12.5%)

8Total

N/A(4)

Phase 4(3)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (15)

Showing 15 of 15 trials

NCT07553780Recruiting

Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate Cancer

Role: collaborator

NCT07553754Recruiting

Plasma Exosomal RNA Signature for Prostate Cancer Bone Metastasis

Role: collaborator

NCT07531329Recruiting

Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate Cancer

Role: collaborator

NCT06065046Phase 2Recruiting

Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions

Role: collaborator

NCT07492927Recruiting

Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate Cancer

Role: collaborator

NCT07474142Recruiting

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

Role: collaborator

NCT04987086Not ApplicableRecruiting

68Ga-PSMA PET in the Renal Cell Carcinoma

Role: collaborator

NCT06604130Not ApplicableEnrolling By Invitation

Plasma Exosome RNA to Diagnose Prostate Cancer

Role: collaborator

NCT05487417Phase 4Recruiting

Effects of Minocycline on Patients With Ischemic Stroke Undergoing Intravenous Thrombectomy

Role: collaborator

NCT04974138Phase 4Recruiting

China Stroke Primary Prevention Trial 2 for Participants With H-type Hypertension and MTHFR 677 CC/CT Genotype (CSPPT2-CC/CT)

Role: collaborator

NCT04974151Phase 4Recruiting

China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

Role: collaborator

NCT05653830Unknown

Observational Clinical Study of the Natural Course and Long-term Prognosis of Patients With Chronic Liver Disease

Role: collaborator

NCT04805034Unknown

Predictive Model for Prognosis of Chronic HBV Infection Mothers

Role: collaborator

NCT03086304Not ApplicableCompleted

Effects of Transcutaneous Acupoint Electrical Stimulation on Intestinal Obstruction After Gastrointestinal Surgery

Role: collaborator

NCT02982655Not ApplicableCompleted

Controlling Hypertension After Severe Cerebrovascular Event

Role: collaborator

All 15 trials loaded